OCIAD2 suppressed tumor growth and invasion via AKT pathway in hepatocellular carcinoma
Carcinogenesis Aug 25, 2017
Wu D, et al. – In this research work, the scientists examined the role of ovarian carcinoma immunoreactive antigen–like protein 2 (OCIAD2) in hepatocellular carcinoma (HCC) progression. Their investigations revealed that reduced expression of OCIAD2 by DNA hypermethylation plays an important role in HCC tumor growth and invasion. In addition, hypermethylation of OCIAD2 probably contributes to HCC treatment development.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries